Health ❯ Therapeutics ❯ Drug Development

Clinical Trials

ADC Therapeutics Glutamate Signaling STING Inhibitors Phase III Trials Repurposing Drugs for ALD KDS2010 Ruxolitinib

MAOB Inhibitor KDS2010 Lifts Astrocytic 'Brake' to Promote Spinal Cord Repair

Researchers trace stalled recovery to tonic GABA that silences BDNF–TrkB signaling, prompting plans for Phase II testing.

Human-Specific STING Inhibitors Block Oligomerization Ahead of Clinical Evaluation

Patient-Derived ALS Models Identify Neuroprotective Drugs and Signaling Clues